Opus Genetics (IRD) Share-based Compensation Growth (1y) (2011 - 2026)
Opus Genetics (IRD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | 60.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.35% |
| Dec 31, 2025 | 4.33% |
| Jun 30, 2025 | 656.82% |
| Mar 31, 2025 | -7.31% |
| Dec 31, 2024 | 344.73% |
| Jun 30, 2024 | -43.32% |
| Mar 31, 2024 | 22.51% |
| Sep 30, 2023 | 16.23% |
| Jun 30, 2023 | 219.55% |
| Mar 31, 2023 | 80.67% |
| Sep 30, 2022 | 1,796.15% |
| Jun 30, 2022 | 1,434.48% |
| Mar 31, 2022 | -9.92% |
| Dec 31, 2021 | -6.63% |
| Sep 30, 2021 | -95.78% |
| Jun 30, 2021 | -90.82% |
| Mar 31, 2021 | 709.84% |
| Dec 31, 2020 | 819.01% |
| Sep 30, 2020 | 579.20% |
| Jun 30, 2020 | 147.55% |